Innovation Pharmaceuticals Inc (IPIX)

[Minnesinger]

I'm not looking to discredit or invalidate...

the the findings in the Promising Role of Defensins Peptides as Therapeutics to Combat Against Viral Infection paper, but let's call a spade a spade: Microbial Pathogenesis is hardly a 'prestigious' journal. In fact, it's an open-access journal. For those who don't know what an open-access journal is, it's where the authors pay to publish. Yes, the paper is reviewed, but it's not even close to NEJM or The Lancet in prestige. The fact we all could access the paper in its entirety, as well as the atypical language in the paper, are hallmarks of pay-to-publish journals.

Here, see for yourself:

https://www.elsevier.com/journals/microbial-pathogenesis/0882-4010/open-access-options

Oh yeah, Viruses is open access, too:

https://www.mdpi.com/journal/viruses